Works matching DE "MONOCLONAL antibodies"


Results: 5000
    1
    2

    Catumaxomab: First Approval.

    Published in:
    Drugs, 2025, v. 85, n. 7, p. 957, doi. 10.1007/s40265-025-02187-9
    By:
    • Syed, Yahiya Y.
    Publication type:
    Article
    3
    4
    5

    Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications.

    Published in:
    OncoImmunology, 2015, v. 4, n. 4, p. 00, doi. 10.1080/2162402X.2015.1008814
    By:
    • Eggermont, Alexander;
    • Marabelle, Aurélien;
    • Zitvogel, Laurence;
    • Buqué, Aitziber;
    • Galluzzi, Lorenzo;
    • Bloy, Norma;
    • Castoldi, Francesca;
    • Tartour, Eric;
    • Kroemer, Guido;
    • Cremer, Isabelle;
    • Galon, Jérôme;
    • Fridman, Wolf Hervé;
    • Aranda, Fernando;
    • Spisek, Radek;
    • Fucikova, Jitka
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12

    Immune checkpoints.

    Published in:
    OncoImmunology, 2014, v. 3, n. 4, p. N.PAG, doi. 10.4161/onci.28325
    By:
    • Chawla, Akhil;
    • Philips, Anne V;
    • Alatrash, Gheath;
    • Mittendorf, Elizabeth
    Publication type:
    Article
    13
    14
    15
    16
    17
    18

    Trial watch Monoclonal antibodies in cancer therapy.

    Published in:
    OncoImmunology, 2013, v. 2, n. 1, p. e22789-1, doi. 10.4161/onci.22789
    By:
    • Vacchelli, Erika;
    • Eggermont, Alexander;
    • Galon, Jérôme;
    • Sautès-Fridman, Catherine;
    • Zitvogel, Laurence;
    • Kroemer, Guido;
    • Galluzzi, Lorenzo
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26

    Developing recombinant antibodies for biomarker detection.

    Published in:
    Cancer Biomarkers, 2010, v. 6, n. 5/6, p. 271, doi. 10.3233/CBM-2009-0144
    By:
    • Baird, Cheryl L.;
    • Fischer, Christopher J.;
    • Pefaur, Noah B.;
    • Miller, Keith D.;
    • Kagan, Jacob;
    • Srivastava, Sudhir;
    • Rodland, Karin D.
    Publication type:
    Article
    27
    28
    29
    30

    Trial Watch: Immunostimulatory cytokines.

    Published in:
    OncoImmunology, 2012, v. 1, n. 4, p. 493, doi. 10.4161/onci.20459
    By:
    • Vacchelli, Erika;
    • Galluzzi, Lorenzo;
    • Eggermont, Alexander;
    • Galon, Jerome;
    • Tartour, Eric;
    • Zitvogel, Laurence;
    • Kroemer, Guido
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Improved quality of life in patients treated with lebrikizumab monotherapy is mediated by improvements in itch and sleep: results from two phase III trials in patients with moderate-to-severe atopic dermatitis Open Access.

    Published in:
    Clinical & Experimental Dermatology, 2025, v. 50, n. 6, p. 1188, doi. 10.1093/ced/llae541
    By:
    • Yosipovitch, Gil;
    • Bruin-Weller, Marjolein de;
    • Wiseman, Marni;
    • Elberling, Jesper;
    • Gutermuth, Jan;
    • Pierce, Evangeline;
    • Montmayeur, Sonia;
    • Yang, Fan Emily;
    • Ding, Yuxin;
    • Bardolet, Laia;
    • Chisolm, Sarah
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50

    Cosibelimab.

    Published in:
    American Journal of Health-System Pharmacy, 2025, v. 82, n. 12, p. 638, doi. 10.1093/ajhp/zxaf055
    Publication type:
    Article